$0.0740
-0.10-58.33%
al cierre: May 14, 5:00 PM EST
Sangamo Therapeutics Inc
SGMOOTC
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadComparar
Sangamo Therapeutics Inc Earnings & Forecasts
Sangamo Therapeutics Inc (SGMO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Sangamo Therapeutics Inc Guidance
Sangamo Therapeutics Inc (SGMO) publicó su última previsión de abril 26, 2023 para Q1 2023. La compañía estimó ingresos en un rango de $158M - $158M para el período.
Recent Earnings Results
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.06 | $-0.02 | $-0.07 | $-0.10 |
| Actual | $-0.08 | $-0.11 | $-0.11 | $-0.08 |
| Surprise | -33.3% | -450.0% | -57.1% | +20.0% |
| Revenue | ||||
| Estimate | $28.9M | $38.1M | $40.6M | $27.1M |
| Actual | $1.4M | $14.2M | $581000 | $18.3M |
| Surprise | -95.0% | -62.8% | -98.6% | -32.4% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q2 '26E | Q3 '26E | Q4 '26E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.04 | $-0.04 | $-0.04 |
| Revenue | |||
| Consensus | $6.4M | $6.4M | — |